The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Navigating the therapeutic landscape of SGLT2 inhibitors in diabetes management: exploring efficacy and emerging concerns”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Han-Wei Yeh, Chung-Hsien Chaou, Shun-Fa Yang, Yu-Hsun Wang, Yu-Hsiang Kuan, Chao-Bin Yeh. SGLT2 inhibitors prevent long-COVID-associated cognitive and pain symptoms in type 2 diabetes patients, Virology Journal. 2025; 23: 27. https://doi.org/10.1186/s12985-025-03054-5 |
|
2 |
2025 |
Yanfei Wang, Minghao Zhou, Zijia Tang, Chenxi Xiong, Breton Asken, Baijian Yang, Jing Su, Xiaobo Zhou, Qianqian Song. 2025; https://doi.org/10.21203/rs.3.rs-8206648/v1 |
|
3 |
2026 |
Jianwei Ma, Qin Su, Hanlu Wang, Jiayan Xu, Chenyi Yuan, Guicai Fan, Jiapei Ying, Xueyan Bian. Efficacy and Safety of Finerenone Combined with Dapagliflozin in the Treatment of Non-Diabetic Chronic Kidney Disease: A Single-Center Retrospective Study, Drug Design, Development and Therapy. 2026; Volume 20: 1. https://doi.org/10.2147/DDDT.S564942 |
|
4 |
2025 |
Shang-Yu Chai, Ru-Ya Zhang, Zhi-Yuan Ning, Yi-Man Zheng, Rajpathak Swapnil, Li-Nong Ji. Sodium-glucose co-transporter 2 inhibitors improve insulin resistance and β-cell function in type 2 diabetes: A meta-analysis, World Journal of Diabetes. 2025; 16: https://doi.org/10.4239/wjd.v16.i7.107335 |